SQZ Biotechnologies Company
SQZB
$0.028
$0.000.00%
OTC PK
09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 10.19M | 24.71M | 39.87M | 63.71M | 84.24M |
Total Receivables | -- | -- | -- | 384.00K | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 1.89M | 2.98M | 4.58M | 4.11M | 3.10M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 12.09M | 27.69M | 44.45M | 68.20M | 87.34M |
|
|||||
Total Current Assets | 12.09M | 27.69M | 44.45M | 68.20M | 87.34M |
Net Property, Plant & Equipment | 15.40M | 24.16M | 26.40M | 29.39M | 64.91M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 2.31M | 2.31M | 2.31M | 2.31M | 2.61M |
Total Assets | 29.79M | 54.15M | 73.16M | 99.90M | 154.85M |
|
|||||
Total Accounts Payable | 1.91M | 1.56M | 2.49M | 2.51M | 3.31M |
Total Accrued Expenses | 4.52M | 5.19M | 5.34M | 12.06M | 7.82M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.40M | 2.66M | 4.19M | 6.56M | 10.63M |
Total Finance Division Other Current Liabilities | -- | 500.00K | 678.00K | 715.00K | 3.50M |
Total Other Current Liabilities | -- | 500.00K | 678.00K | 715.00K | 3.50M |
Total Current Liabilities | 8.83M | 9.91M | 12.69M | 21.84M | 25.26M |
|
|||||
Total Current Liabilities | 8.83M | 9.91M | 12.69M | 21.84M | 25.26M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 19.08M | 19.70M | 20.31M | 20.91M | 51.82M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | 9.20M |
Total Liabilities | 27.91M | 29.61M | 33.00M | 42.75M | 86.28M |
|
|||||
Common Stock & APIC | 334.95M | 333.97M | 332.82M | 332.12M | 330.00M |
Retained Earnings | -333.07M | -309.43M | -292.66M | -274.97M | -261.43M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 1.88M | 24.54M | 40.16M | 57.15M | 68.57M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 1.88M | 24.54M | 40.16M | 57.15M | 68.57M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 1.88M | 24.54M | 40.16M | 57.15M | 68.57M |
|